Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
14,649,709
-
Shares change
-
+928,721
-
Total reported value, excl. options
-
$503,022,059
-
Value change
-
+$23,340,307
-
Put/Call ratio
-
195%
-
Number of buys
-
62
-
Number of sells
-
50
-
Price
-
$34.31
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2021
As of 31 Dec 2021 CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) had 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,649,709 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, Bill & Melinda Gates Foundation, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, NORGES BANK, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and VOLORIDGE INVESTMENT MANAGEMENT, LLC.
This table shows 163 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.